Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect
Author:
Affiliation:
1. Department of Chemotherapy, Cancer Center, Qilu Hospital, Shandong University, Ji’nan, P.R. China and
2. Department of Otorhinolaryngology Head and Neck Surgery, Provincial Hospital affiliated to Shandong University, Ji’nan, P.R. China
Publisher
Informa UK Limited
Subject
Pharmaceutical Science,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.3109/10717544.2015.1055619
Reference25 articles.
1. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers – A systematic review of in vitro data
2. Curcumin-loaded mixed micelles: preparation, optimization, physicochemical properties and cytotoxicityin vitro
3. Synergistic co-delivery of doxorubicin and paclitaxel by porous PLGA microspheres for pulmonary inhalation treatment
4. Nanostructured lipid carriers system: Recent advances in drug delivery
5. Randomized, Phase III Trial of First-Line Figitumumab in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Patients With Advanced Non–Small-Cell Lung Cancer
Cited by 97 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Enhancing pulmonary delivery and immunomodulation of respiratory diseases through virus-mimicking nanoparticles;Journal of Controlled Release;2024-08
2. Lipid Nanoparticles in Lung Cancer Therapy;Pharmaceutics;2024-05-10
3. Co-delivery of paclitaxel and curcumin loaded solid lipid nanoparticles for improved targeting of lung cancer: In vitro and in vivo investigation;Heliyon;2024-05
4. Nanostructured lipid carriers (NLCs): A promising candidate for lung cancer targeting;International Journal of Pharmaceutics;2024-04
5. Nanocarrier-Mediated Drug Delivery via Inhalational Route for Lung Cancer Therapy: A Systematic and Updated Review;AAPS PharmSciTech;2024-02-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3